Patents expiring in 2031

US 7982014

FGFR3-IIIc fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7981869

RNAi modulation of RSV and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985401

Peptides whose uptake by cells is controllable

The Regents of the University of California · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985748

ALPHA2C adrenoreceptor agonists

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985863

Iminopyridine derivatives and uses thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985762

Inhibitors of serine proteases

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985581

Multiple RNA polymerase III promoter expression constructs

Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985428

Method and composition for modulation of systemic inflammatory responses syndrome (SIRS)

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985601

Tunable, semi-interpenetrating polymer networks (sIPNS) for medicine and biotechnology

The Regents of the University of California · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985783

Aldehyde tags, uses thereof in site-specific protein modification

The Regents of the University of California · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985769

Compounds and methods for the treatment or prevention of Flavivirus infections

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985836

Antimicrobial peptides and methods of identifying the same

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985862

Iminopyridine derivatives and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7985887

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7988958

Enterococcus and Streptococcus strains and bacteriocins

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7988956

Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)

Nektar Therapeutics · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7988685

Hydrogel compositions, devices, and microscale components

Regents of the University of Minnesota · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989498

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989484

Dual-acting antihypertensive agents

Theravance, Inc. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989500

Synthesis, methods of using, and compositions of cycloalkylmethylamines

REVIVA PHARMACEUTICALS, INC. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989501

Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7988971

Human monoclonal antibodies against Hendra and Nipah viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989456

Pyrazine kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989473

Stable laquinimod preparations

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989481

Indane derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7988967

High affinity human antibodies to human nerve growth factor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7988977

Modified live Aeromonas hydrophila vaccine for aquatic animals

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989445

Thienopyrimidone compound

Takeda Pharmaceutical Company Limited · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989448

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7989430

Antibacterial agents

Regents of the University of Minnesota · Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994306

Methods of treating cancer using siRNA molecules directed against CD24

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994299

Compositions and methods for increasing bone mineralization

Darwin Discovery Limited · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994326

Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthase

Northwestern University · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994307

RNAi modulation of the BCR-ABL fusion gene and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994309

Compositions and methods for inhibiting expression of a mutant gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994191

Heterocyclic cyclopamine analogs and methods of use thereof

Infinity Discovery, Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994183

Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile

Takeda Pharmaceutical Company Limited · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994193

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

ACADIA Pharmaceuticals Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994209

3-phenoxymethylpyrrolidine compounds

Theravance, Inc. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994226

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994211

Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses

Argenta Discovery Limited · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994332

Process for producing crystal

Takeda Pharmaceutical Company Limited · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7993648

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

The Regents of the University of Colorado · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7993919

Method of inducing memory B cell development and terminal differentiation

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994132

Peptides for treatment of scleroderma

The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994166

Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatment of pain

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994205

Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7994320

Narcistatin prodrugs

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)